CFO Tobin Schilke sold $101K of Revance Therapeutics, Inc.

Sold$100,525

$27.16Price

3,701Shares

−6%Stake

What RVNC did after the filing

Prices for RVNC after this filing aren't in yet.

Traded Mon, Jan 9. Filed Tue, Jan 10, 3:06 PM ET, during the session. Not investment advice.